secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-10-02T20:01:29+00:00
Accession:  0001401914-26-000052
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Daré Bioscience gets Nasdaq bid-price deficiency notice, has until March 29, 2027 to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified Daré on September 28, 2026 that DARE's closing bid price was below the $1.00 minimum for 30 consecutive business days.
- Daré has 180 calendar days, until March 29, 2027, to regain compliance under Nasdaq Listing Rule 5550(a)(2); the notice has no immediate listing effect.
- Compliance requires a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.
- If not cured, Daré may qualify for an additional 180-day period, but failure could lead to delisting and a Nasdaq Hearing Panel appeal.
- Daré said it will monitor its closing bid price and consider options to regain compliance, with no assurance it will succeed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000052/0001401914-26-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000052/dare-20260928.htm
  HTML page:      https://secwatch.observer/filing/0001401914-26-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer